[Story ID: 3270] Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks
Microsoft Patents New Xbox 360 ControllerIGNA patent filed by Microsoft earlier this year and approved by the US Patent and Trademark Office this week suggests that the company could … and more
[Story ID: 2973] Healthcare Trust of America, Inc., a self-managed, non-traded, real estate investment trust, announced the acquisition of a medical office building located in Stockbridge, Georgia for approximately $8,140,000.
[Story ID: 2466] Cequent Pharmaceuticals said this week that it has received notices that the European Patent Office and the Korean Intellectual Property Office intend to grant patents covering the company’s core RNAi technology.
[Story ID: 2452] The U.S. Patent and Trademark Office has reaffirmed two patents by which virtual-private-network firm VirnetX sued Microsoft in a legal battle against the company’s big boys: Windows and Office.
[Story ID: 2365] Farzad Mostashari, a senior official in the government’s health IT office, said in a speech Tuesday that the strategy for implementing federal ehealth efforts is one of “bold incrementalism,” Modern Healthcare reports. Mostashari listed as an example the Office of the National Coordinator for Health IT’s “approach to the health information exchange.
[Story ID: 2344] MANITOWOC, Wis. — Orion Energy Systems, Inc. on June 1 was issued two patents from the U.S. Patent and Trademark office for components of its exterior lighting technology.
[Story ID: 2132] Kaiser Health News reports that the insurance industry ‘
[Story ID: 1910] The United States Patent and Trademark Office (USPTO) is increasing the availability of its patent electronic filing system, Electronic Filing System’
[Story ID: 1911] US Pat. No. 5,053,407, exclusively licensed to Ortho-McNeil Pharmaceutical, is directed to an enantiomer of a racemic compound that had previously been approved by the Food and Drug Administration (FDA). On judgment, the district court agreed with the positions of the Patent and Trademark Office and the FDA, and held that the [...]